Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine

Am J Hematol. 2020 Aug;95(8):E194-E196. doi: 10.1002/ajh.25862. Epub 2020 Jun 18.

Authors

Maria T Kuipers¹, Rob van Zwieten², Jarom Heijmans¹, Caroline E Rutten¹, Koen de Heer^{1

3}, Arnon P Kater¹, Erfan Nur¹

Affiliations

¹ Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
² Laboratory for Red Blood Cell Diagnostics, Sanquin, Amsterdam, The Netherlands.
³ Department of hematology, Flevoziekenhuis, Almere, The Netherlands.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Chloroquine / adverse effects*
Coronavirus Infections / blood
Coronavirus Infections / complications
Coronavirus Infections / drug therapy*
Glucosephosphate Dehydrogenase Deficiency / blood*
Hemolysis / drug effects*
Humans
Male
Methemoglobinemia / chemically induced*
Middle Aged
Pandemics
Pneumonia, Viral / blood
Pneumonia, Viral / drug therapy*
SARS-CoV-2

Substances

Chloroquine